Guidance. Clarity. Direction.

Carter, DeLuca & Farrell LLP, a leader in intellectual property law, provides cost-effective services to clients from around the world, protecting innovations in a wide range of technologies.

Throughout the phases of product or brand development, we form a critical part of our clients’ development teams to provide preparation, prosecution and clearance services to maximize protection while navigating through freedom-to-operate challenges. We also provide extensive IP due diligence services and IP asset assimilation to help our clients achieve their business objectives.

Search Attorneys

Events

May
22 – 23
2019
21st Future of Health Technology Summit at MIT Attending SponsoringGeorge Likourezos, partner, will present on the panel Future IP and Legal Issues in AI-driven Drug Development at the 21st Future of...

CAFC Update

NOVARTIS PHARMACEUTICALS CORP v. WEST-WARD PHARMACEUTICALS May 13, 2019

West-Ward Pharmaceuticals appeals the decision of the District Court holding that claims of U.S. Patent No. 8,410,131 which claims methods of using the compound everolimus (an mTOR inhibitor and the active ingredient in Novartis’s Afinitor product) to treat advanced renal cell carcinoma (“RCC”), would not have been obvious in view of the prior art. The CAFC

West-Ward Pharmaceuticals appeals the decision of the District Court holding that claims of U.S. Patent No. 8,410,131 which claims methods of using the...

AVX CORPORATION v. PRESIDIO COMPONENTS, INC.

AVX petitioned for an inter partes review (IPR) of all claims of Presidio’s U.S. Patent No. 6,661,639 (which describes and claims single-layer ceramic capacitors with certain features) based on obviousness. The Patent Trial and Appeal Board issued a final written decision holding some claims unpatentable, but that AVX had failed to establish unpatentability of other claims. AVX...

AVX petitioned for an inter partes review (IPR) of all claims of Presidio’s U.S. Patent No. 6,661,639 (which describes and claims single-layer ceramic...

BRADIUM TECHNOLOGIES LLC v. IANCU

Bradium Technologies LLC appealed final written decisions of the Patent Trial and Appeal Board finding the claims of U.S. Patent Nos. 7,908,343 and 8,924,506 unpatentable as obvious in two inter partes review proceedings. The patents are directed to retrieving large-scale images over network communication channels in low-bandwidth conditions and to displaying such images on client devices with limited processing power. ...

Bradium Technologies LLC appealed final written decisions of the Patent Trial and Appeal Board finding the claims of U.S. Patent Nos. 7,908,343 and 8,924,506...